Description
BLOOD AND BLOOD RELATED PRODUCTS AND SERVICES
First action · last action
2020-10-01 · 2025-09-02
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$3,137,588
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-10-01+$0= $0
- Mod P000012023-09-06+$0= $0
- Mod P000022025-09-02+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-10-01 | +$0 | $0 | BLOOD AND BLOOD RELATED PRODUCTS AND SERVICES |
| Mod P00001· EXERCISE AN OPTION | 2023-09-06 | +$0 | $0 | BLOOD AND BLOOD RELATED PRODUCTS AND SERVICES |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2025-09-02 | +$0 | $0 | BLOOD AND BLOOD RELATED PRODUCTS AND SERVICES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SCFJBJWLMXT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0050 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25626N0450 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $324,605 | FY2026 |
| 36C25626N0432 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $245,189 | FY2026 |
| 36C25626N0069 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,008 | FY2026 |
| 36C25625N0652 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $162,292 | FY2025 |
| 36C25625N0007 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $307,339 | FY2025 |
Other recipients under 6550 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626P0524 | ROCHE DIAGNOSTICS CORPORATION | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $134,375 | FY2026 |
| 36C25626N0413 | TOSOH BIOSCIENCE, INC. | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $32,760 | FY2026 |
| 36C25626N0406 | CEPHEID | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $800,000 | FY2026 |
| 36C25626D0035 | CEPHEID | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $0 | FY2026 |
| 36C25626P0326 | CEPHEID | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $379,242 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C25621D0011_3600 · retrieved 2026-09-26.